user-generated· price
Novo Nordisk stock rises 10% within 3 months of Wegovy pill launch
Novo Nordisk's stock will appreciate by at least 10% from the date of the Wegovy pill's private launch, reflecting investor optimism about the oral formulation's market penetration potential and its impact on revenue growth. The increase will be attributed to analyst upgrades and sales forecasts.
price · Prediction Market
- Implied probability (Yes)
- 60%
- Closes
- 2026-10-06
More price markets
- Samsung Electronics market cap to exceed $1.2T by Q3 2026 — 78% Yes
- Cisco stock to rise above $65 by Q3 2026 — 72% Yes
- Private jet charter prices increase 20% in 2027 — 75% Yes
- Google Messages sees 30% user growth in 6 months post-launch — 70% Yes
- US AI chip ETF doubles in value by 2026-09-30 — 65% Yes
- X’s stock price rises 10% within 3 months of History tab launch — 55% Yes
- TSK enters top 5 Spanish engineering firms by market cap — 60% Yes
- Ford stock volatility exceeds 60% annualized within 6 months — 75% Yes
Loading…